LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated System for SARS-CoV-2 Analysis in Wastewater to Enable Early Detection of COVID-19 Prevalence and Mutants

By LabMedica International staff writers
Posted on 22 Mar 2021
Print article
Image: Automated System for SARS-CoV-2 Analysis (Photo courtesy of Robotic Biology Institute Inc.)
Image: Automated System for SARS-CoV-2 Analysis (Photo courtesy of Robotic Biology Institute Inc.)
A joint project aims to establish an automated analytical system that enables mass diagnosis by early detection of viral disease prevalence and mutants, based on wastewater-based epidemiology.

Hokkaido University (Sapporo, Japan) and Robotic Biology Institute Inc. (RBI; Tokyo, Japan), along with iLAC Co., Ltd., and Shionogi & Co., Ltd. have entered into a memorandum of understanding (MOU) for the establishment of an automated system for the analysis of the novel coronavirus (SARS-CoV-2) in wastewater.

It has been suggested that the novel coronavirus (SARS-CoV-2) can propagate by infecting intestinal epithelial cells. SARS-CoV-2 has been detected in the feces of a significant proportion of infected individuals including those without gastrointestinal symptoms. SARS-CoV-2 excreted in the feces of COVID-19 patients eventually come together at wastewater treatment plants. Therefore, research into wastewater-based epidemiology (WBE) of SARS-CoV-2, which acquires population-level epidemiological information by routine monitoring of the virus in wastewater, has been accelerating across the world. WBE has been reported in scientific papers to be extremely useful for early detection of the spread of COVID-19 and the confirmation of successful mitigation of the disease prevalence in a given region.

In Japan, there have been fewer reported cases of COVID-19 infection per capita compared to the US and some European countries and regions, and therefore, the concentrations of SARS-CoV-2 in Japanese wastewater tend to be lower than those in other countries. Hokkaido University and Shionogi had entered into a collaborative research agreement in October 2020 to develop a virus detection method with an increased sensitivity. As a result of the collaborative research, a highly sensitive method of SARS-CoV-2 detection in wastewater has been successfully developed.

For societal implementation of WBE, the establishment of a high throughput analysis system of the collected wastewater samples is urgently needed. For this purpose, RBI and iLAC have joined the existing collaborations between Hokkaido University and Shionogi. RBI has the technology for automated SARS-CoV-2 detection/quantification and library preparation for next-generation sequencing (NGS) analysis using LabDroid “Maholo,” a versatile humanoid robot made in Japan; iLAC is capable of elucidating genomic information (e.g., viral genome mutations) based on massive NGS analysis. They will help develop an automated analysis system for WBE of SARS-CoV-2.

Related Links:
Hokkaido University
Robotic Biology Institute Inc.


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.